EMG
AH

Ellington Management Group’s Accretive Health AH Stock Holding History

Ellington Management Group’s Portfolio AH Stock Details AH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-39,800
Closed -$430K – 1148
2013
Q2 		$430K Buy
+39,800
New +$419K 0.08% 377

Other funds holding AH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JRP
Jasper Ridge Partners Menlo Park, California $4.69B AUM 31.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ellington Management Group's AH Position: Q3 2013 in Review

Ellington Management Group sold out of Accretive Health (AH) in Q3 2013, closing a stake of 39,800 shares — an estimated $430K sold.

Ellington Management Group first reported a position in AH in Q2 2013 and held it in 1 quarter. The position peaked at $430K in Q2 2013. 99 funds tracked by Wall St. Rank hold AH as of Q3 2013.

  • Ellington Management Group reported no remaining Accretive Health position as of Q3 2013 after selling out during the quarter.
  • Ellington Management Group sold 39,800 Accretive Health shares in Q3 2013, an estimated $430K.
  • Ellington Management Group first reported a position in Accretive Health in Q2 2013 and held it in 1 quarter.
  • Ellington Management Group's Accretive Health position peaked at $430K in Q2 2013.
  • 99 funds tracked by Wall St. Rank held Accretive Health as of Q3 2013.

Based on Ellington Management Group's 13F filing for Q3 2013, filed 14 Nov 2013.